Perspectives on cancer therapy—synthetic lethal precision medicine strategies, molecular mechanisms, therapeutic targets and current technical challenges Nature Nawigacja wpisu Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation – PR Newswire Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union – Biogen
